Stamford, CT -- (SBWIRE) -- 01/30/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Creative Edge Nutrition Inc (OTCMKTS:FITX), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), J.C. Penney Company, Inc. (NYSE:JCP), Rite Aid Corporation (NYSE:RAD).
Creative Edge Nutrition Inc (OTCMKTS:FITX) opened its last trade at the price of $0.06. Its closing price was $0.0540 after gaining 17.39% for the day. The company traded with the total volume of 189.88 million shares, while its average trading volume remained 1231.92 million shares. The beta of this stock stands at-1.72.Creative Edge Nutrition, Inc., a nutritional supplement company, develops, markets, and sells nutraceuticals and health supplements. It offers a range of capsules, tablets, and powders, as well as science based products in weight management, specific nutrition challenges, energy, and fitness categories.
For How Long FITX will Fight for Profitability? Read This Trend Analysis report
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) percentage change plunged-27.42% to close at $4.50 with the total traded volume of 7.80 million shares, along with average volume of 1.17 million shares. The 52 week range of the stock remained $2.53 - $7.45, while its day lowest price was $4.31. The share price hit the day highest price of $5.48.Progenics Pharmaceuticals, Inc. engages in the research and development of biotechnology product candidates in the areas of oncology and therapeutics worldwide. The company offers RELISTOR (methylnaltrexone bromide), a subcutaneous injection for the treatment of opioid induced constipation (OIC) in patients with advanced illnesses, such as cancer.
Has PGNX Found The Bottom And Ready To Gain Momentum? Find Out Here
J.C. Penney Company, Inc. (NYSE:JCP) traded on volume of 18.54 million shares in the last session against average volume of 25.42 million shares. The company started its trading session with the price of $6.40 and closed at $6.29 by scoring -2.02%.J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates department stores. It sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings. The company also provides various services, such as styling salon, optical, portrait photography, and custom decorating.
Why Should Investors Buy JCP After the Recent Fall? Just Go Here and Find Out
Rite Aid Corporation (NYSE:RAD) started its last trading session with the price of $5.46 and closed at $5.36 by scoring -3.42%. The stock traded with total volume of 26.97 million shares, while the average trading volume remained 26.97 million shares. The beta value of this stock stands at 2.38. Day range for the stock was $5.33 - $5.52.Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Will RAD Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)